FDA Inspection 1065132 — New York Blood Center Enterprises
The FDA completed an inspection of New York Blood Center Enterprises on July 31, 2018 in Rockville Centre, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 31, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Rockville Centre, NY (United States)